Promegestone


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : PO Mastalgia; Menstrual disorders; Progestogen component of menopausal HRT125-500 mcg/day on a cyclical basis.
Dosage Details
Oral
Mastalgia, Menstrual disorders, Progestogen component of menopausal hormonal replacement therapy
Adult: 125-500 mcg daily on a cyclical basis.
Contraindications
Undiagnosed vag bleeding, severe hepatic impairment, pregnancy testing. Pregnancy. History or current high risk of arterial disease.
Special Precautions
CV or renal impairment, diabetes mellitus, asthma, epilepsy, migraines, history of depression, conditions which may be aggravated by fluid retention. Lactation.
Adverse Reactions
GI disturbances, changes in appetite or weight, oedema, acne, chloasma, breast changes, hirsutism, headache, insomnia, altered menstrual cycles, breakthrough bleeding. Alterations in serum lipid profile.
Drug Interactions
Enzyme-inducing drugs may enhance clearance. May inhibit ciclosporin metabolism.
Action
Description: Promegestone is a progestogen structurally related to progesterone.
Disclaimer: This information is independently developed by MIMS based on Promegestone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in